Slide 1SPIRIT IV A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease One Year Clinical…

Slide 1 MINIMASTER: PREVENZIONE DELLE RECIDIVE E ADERENZA ALLE TERAPIE GLICEMIA A DIGIUNO, POST-PRANDIALE O HbA1c: COME IMPOSTARE IL CONTROLLO A LUNGO TERMINE Sandro Gentile…

Slide 1 What’s New in Diabetes Maeve C. Durkan MBBS, FACP, Mmed.Ed Consultant in Diabetes, Endocrinology & Metabolism Slide 2 New Drugs …. Incretins & Pancreatitis/…

Slide 1 The Art and Science of Insulin Thomas Repas D.O. Diabetes, Endocrinology and Nutrition Center, Affinity Medical Group, Neenah, Wisconsin Member, Inpatient Diabetes…

Slide 1 IMPLICATIONS OF UKPDS GSK Advisory Board 24 May 2003 Dr. J. R. Conway Slide 2 Worldwide rates of diabetes mellitus: predictions 80 70 60 50 40 30 20 10 0 Prevalence…

Slide 1 Issues in Diabetes Care Academic Half-day February 2002 D. Hunt Slide 2 Outline 1. Significance of diabetes mellitus 2. Glycemic control:- evidence - oral agents…

Slide 1 Why Patients are Reluctant to Start Insulin, and What to Do About it William H. Polonsky, PhD, CDE January 30, 2009 [email protected] Slide 2 Potential Consequences…

FDA Endocrinologic and Metabolic Drugs Advisory Committee 1st June 2008 Rury Holman Clinical outcomes with anti-diabetic drugs: What we already know The “Deadly Quintet”…

Metabolic Alterations in Children with Obstructive Sleep Apnea Bharat Bhushan, PhD Department of Surgery Division of Otolaryngology-Head and Neck Surgery Ann and Robert H.…

Issues in Diabetes Care Academic Half-day February 2002 D. Hunt Outline 1. Significance of diabetes mellitus 2. Glycemic control: - evidence - oral agents - insulin 3. Blood…